2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

There was no difference in the MACE effect in the subpopulations with and without a history of CVD, although the treatment effect of dulaglutide did not reach statistical significance when the groups were considered separately.

also in 111,027 other papers